drugset / Trial / NCT03003000

Ibuprofen/Caffeine Lower Back or Neck Pain Study

NCT03003000 ↗

Phase 3 Completed 635 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.

Timeline

Start
2016-12-20
Primary completion
2017-09-24
Completion
2017-09-28

Outcome

Missed primary endpoint

registry analysis (superiority test); Placebo vs Ibuprofen and Caffeine; p = 0.3446; Mean Difference (Final Values) 0.156 (95% CI -0.168 to 0.480) NCT03003000 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg —
Subject Ibuprofen Small molecule 400 mg —

Indications

No indication recorded.